Tavapadon Improves Early PD Symptoms: Full Phase 3 Results

Published Date: 18 Jul 2026

The selective D1/D5 agonist significantly improved Parkinson’s disease motor symptoms, with low rates of somnolence and impulse control disorders, full results of the phase 3 TEMPO-2 study show.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Do Anatomy Atlases Reflect Social Inequalities?

2.

In Resectable Lung Cancer, Perioperative Nivolumab Increases EFS.

3.

Mammography with AI support is a secure method for detecting breast cancer.

4.

QOL Maintained With Giredestrant Combo in Advanced BC

5.

Talc Powder Not Linked to Lung Cancer in Women


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot